shock (ECS) enhances neurotransmitter release and activates NOS (
To ascertain the specific cysteines involved in the S-nitrosylation of NSF, we conducted MALDI-mass spectrometric analysis of NSF in the presence of GSNO followed by labeling the S-nitrosylated cysteines with HPDP-biotin ( Figure 1G ). This procedure identifies cysteine-91 as the S-nitrosylated residue.
NSF is comprised of three domains: the D1 domain, which mediates ATP hydrolysis; the D2 domain, which participates in homo-oligomerization; and the N-terminal domain, which mediates binding to other proteins (Whiteheart and Matveeva, 2004) . Each of these contains three conserved cysteines. To obtain more defin- Figure 3A ). This induction is completely blocked both by the NMDAR antagonist MK801 and the NOS inhibitor L-NAME, indicating that activation of synaptic NMDAR is sufficient to stimulate NOS activity. Glycine treatment leads to NSF S-nitrosylation, which is abolished by MK801 or L-NAME ( Figures 3B and 3C ). To investigate whether S-nitrosylation of NSF promotes surface expression of GluR2 in neurons, we initially employed TIRFM in neurons as we did in HEK 293 cells. Glycine treatment induces a rapid Figures 4C and 4E) , confirming that 
